Learn More
Medchemexpress LLC Nampt-IN-5 | 2380013-17-0 | 98.0% | C25H25N5O2 | 10MG

Supplier: Medchemexpress LLC HY13060610MG
Nampt-IN-5 is a research-stage small molecule inhibitor of nicotinamide phosphoribosyltransferase (NAMPT) that demonstrates potent antiproliferative activity in cancer cell lines and has documented metabolic interaction with CYP3A4. The compound is characterized by a defined purity and recommended solvent/formulation guidance for both in vitro and in vivo studies, and is intended for research use only.
- Potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with sub-nanomolar cellular activity.
- Demonstrated cellular IC50s of 0.7 nM (A2780) and 3.9 nM (COR-L23).
- Inhibits CYP3A4, enabling metabolic interaction studies.
- High purity (98.02%) suitable for research applications.
- Soluble in DMSO and compatible with recommended in vivo formulations.
- Stable as a powder at -20°C; follow solvent storage guidelines for solutions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.